Hematopoietic Stem-Cell Transplantation for Children with Hodgkin’s and Non-Hodgkin’s Lymphoma

Bruce Gordon, K. Scott Baker

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Non-Hodgkin’s lymphomas (NHL) account for 7% of all cancers in children younger than 20 years of age (1), with about 800 new cases diagnosed each year in the United States, an incidence of approximately 1 per 100,000. The incidence of NHL rises steadily throughout life, though the agespecific incidence of various subcategories varies markedly. Overall, more than 70% of children and adolescents with NHL will survive at least 5 years. Outcome is variable depending on a number of factors, including disease subtype and extent of disease at diagnosis (2).

Original languageEnglish (US)
Title of host publicationPediatric Hematopoietic Stem Cell Transplantation
PublisherCRC Press
Pages529-554
Number of pages26
ISBN (Electronic)9780849358807
ISBN (Print)9780824724450
DOIs
StatePublished - Jan 1 2006

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Hematopoietic Stem-Cell Transplantation for Children with Hodgkin’s and Non-Hodgkin’s Lymphoma'. Together they form a unique fingerprint.

Cite this